XML 23 R7.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Accumulated Earnings
Accumulated Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Loss
Non-Controlling Interest
Beginning balance (in shares) at Dec. 31, 2019     72,000,261          
Beginning balance at Dec. 31, 2019 $ 271,623 $ (74) $ 720 $ 0 $ 296,476 $ (74) $ (30,009) $ 4,436
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Share-based compensation recognized $ 14,253     14,253        
Repurchase of common stock (in shares) (300,000)   (336,022)          
Repurchase of common stock $ (7,300)   $ (3) (775) (6,522)      
Restricted stock units delivered (in shares)     473,439          
Restricted stock units delivered (8,134)   $ 4 (8,138)        
Net income (loss) 104,851       104,436     415
Cash dividends declared on common stock, $0.20 per share (14,382)       (14,382)      
Other comprehensive income (loss) (18,408)           (18,245) (163)
Ending balance (in shares) at Dec. 31, 2020     72,137,678          
Ending balance at Dec. 31, 2020 342,429   $ 721 5,340 379,934   (48,254) 4,688
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Share-based compensation recognized $ 14,799     14,799        
Repurchase of common stock (in shares) (600,000)   (614,288)          
Repurchase of common stock $ (24,388)   $ (6) (5,080) (19,302)      
Restricted stock units delivered (in shares)     446,466          
Restricted stock units delivered (8,792)   $ 4 (7,494) (1,302)      
Net income (loss) 161,143       161,130     13
Cash dividends declared on common stock, $0.20 per share (14,409)       (14,409)      
Other comprehensive income (loss) $ (514)           131 (645)
Ending balance (in shares) at Dec. 31, 2021 71,969,856   71,969,856          
Ending balance at Dec. 31, 2021 $ 470,268   $ 719 7,565 506,051   (48,123) 4,056
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Share-based compensation recognized $ 19,956     19,956        
Repurchase of common stock (in shares) (2,800,000)   (2,810,182)          
Repurchase of common stock $ (96,596)   $ (28) (21,833) (74,735)      
Restricted stock units delivered (in shares)     276,719          
Restricted stock units delivered (5,685)   $ 3 (5,688)        
Net income (loss) 238,869       239,009     (140)
Cash dividends declared on common stock, $0.20 per share (13,773)       (13,773)      
Common stock received in exchange of the sale of a Business (in shares)     (4,589,160)          
Common stock received in exchange of the sale of a Business (169,249)   $ (46)   (169,203)      
Other comprehensive income (loss) $ 30,958           31,637 (679)
Ending balance (in shares) at Dec. 31, 2022 64,847,233   64,847,233          
Ending balance at Dec. 31, 2022 $ 474,748   $ 648 $ 0 $ 487,349   $ (16,486) $ 3,237